TARO Taro Pharmaceutical Industries Ltd

Taro Pharmaceutical Industries Ltd is a science-based pharmaceutical company. It develops, manufacture and market Rx and OTC (over-the-counter) pharmaceutical products primarily in the United States, Canada and Israel.

$23.95  -0.40 (-1.64%)
As of 03/27/2023 14:23:53 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  Israel
Country of incorporation:  Israel
IPO date:  02/11/2013
Outstanding shares:  37,584,631
Average volume:  17,255
Market cap:   $905,037,914
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      2872423

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%